TheraTears® Launches Innovative Dry Eye Solutions for Enhanced Comfort Discover TheraTears® new products designed specifically for dry eye relief, featuring Eyelid Cleansing Wipes and preservative-free eye drops for immediate comfort.

TheraTears® Launches Innovative Dry Eye Solutions for Enhanced Comfort #United_States #Tarrytown #Dry_Eye #eye_drops #TheraTears

New Survey Highlights the Widespread Impact of Dry Eye Symptoms in the United States A recent survey reveals that 3 in 4 Americans experience dry eye symptoms weekly, largely due to lifestyle factors and increased screen time.

New Survey Highlights the Widespread Impact of Dry Eye Symptoms in the United States #United_States #Tarrytown #Dry_Eye #TheraTears #OxyLytes

Nordic Group B.V. Shares Insights on LACRIFILL® Canalicular Gel for Dry Eye Treatment at AAO 2025 Nordic Pharma, a subsidiary of Nordic Group B.V., details the promising results of LACRIFILL® at the American Academy of Ophthalmology 2025 meeting.

Nordic Group B.V. Shares Insights on LACRIFILL® Canalicular Gel for Dry Eye Treatment at AAO 2025 #USA #Orlando #Nordic_Pharma #LACRIFILL #Dry_Eye

Nordic Pharma Set to Showcase Innovative LACRIFILL Gel at 2025 AAO Conference At the 2025 American Academy of Ophthalmology conference, Nordic Pharma will present its groundbreaking LACRIFILL gel for dry eye treatment, sharing patient insights and treatment efficacy.

Nordic Pharma Set to Showcase Innovative LACRIFILL Gel at 2025 AAO Conference #USA #Orlando,_Florida #Nordic_Pharma #LACRIFILL #Dry_Eye

Nordic Pharma to Showcase LACRIFILL Canalicular Gel at AAO 2025 in Orlando Nordic Pharma will present its LACRIFILL Canalicular Gel at the AAO 2025 meeting, highlighting patient data that showcases its effectiveness for dry eye treatment.

Nordic Pharma to Showcase LACRIFILL Canalicular Gel at AAO 2025 in Orlando #USA #Orlando #Nordic_Pharma #LACRIFILL #Dry_Eye

Exploring the Potential Benefits of VR Headsets on Dry Eye Syndrome A groundbreaking study suggests that using VR headsets may help alleviate symptoms of dry eye. Observations of tear film dynamics provide insights into this phenomenon.

Exploring the Potential Benefits of VR Headsets on Dry Eye Syndrome #Japan #Tokyo #VR_Headset #Dry_Eye #Tear_Film

LACRIFILL® Canalicular Gel Featured in Latest DEWS III Report on Dry Eye Management Nordic Pharma's canalicular gel, LACRIFILL®, has been included in the DEWS III report published by the Tear Film and Ocular Surface Society.

LACRIFILL® Canalicular Gel Featured in Latest DEWS III Report on Dry Eye Management #USA #Berwyn #Nordic_Pharma #Dry_Eye #LACRIFILL®

Nordic Pharma's Lacrifill Canalicular Gel Introduced in Major Dry Eye Report Nordic Pharma, a subsidiary of Nordic Group B.V., announces Lacrifill Canalicular Gel's inclusion in a vital report on dry eye management and therapy.

Nordic Pharma's Lacrifill Canalicular Gel Introduced in Major Dry Eye Report #USA #Berwyn #Nordic_Pharma #LACRIFILL #Dry_Eye

LACRIFILL® Canalicular Gel Featured in DEWS III Report by TFOS Nordic Pharma announces its LACRIFILL® Canalicular Gel has been included in the DEWS III report. This new therapy for dry eye emphasizes significant advancements in treatment.

LACRIFILL® Canalicular Gel Featured in DEWS III Report by TFOS #USA #Berwyn #Nordic_Pharma #Dry_Eye #LACRIFILL®

Tixel i® Proves Effective for Patients with Dry Eye Disease in Recent Study Recent findings reveal that Tixel i® significantly alleviates symptoms for patients with Evaporative Dry Eye Disease, enhancing quality of life and satisfaction.

Tixel i® Proves Effective for Patients with Dry Eye Disease in Recent Study #USA #Knoxville #Dry_Eye #Novoxel #Tixel_i®

New York's Premier Ophthalmologist Leverages Tixel® Technology to Transform Dry Eye Treatments Leading ophthalmologist Dr. Noaman Sanni integrates Tixel® technology into his practice, revolutionizing dry eye treatments and seeing substantial growth.

New York's Premier Ophthalmologist Leverages Tixel® Technology to Transform Dry Eye Treatments #United_States #New_York #Dry_Eye #Novoxel #Tixel

FDA Approves IND Clearance for Innovative Immunoglobulin Eye Drops Targeting Dry Eye Disease Selagine, Inc. announces FDA's clearance for their immunoglobulin eye drops aimed at alleviating symptoms for dry eye disease patients, marking a significant advancement.

FDA Approves IND Clearance for Innovative Immunoglobulin Eye Drops Targeting Dry Eye Disease #USA #Chicago #Dry_Eye #Selagine #Immunoglobulin

Nordic Pharma Reveals New Dry Eye Treatment at ASCRS Annual Meeting Nordic Pharma, Inc. presents significant findings on LACRIFILL® Canalicular Gel for dry eye relief at the ASCRS Annual Meeting in Los Angeles, demonstrating a promising path forward.

Nordic Pharma Reveals New Dry Eye Treatment at ASCRS Annual Meeting #United_States #Los_Angeles #Nordic_Pharma #LACRIFILL #Dry_Eye